Click for best price
Anemia Treatment Drugs Market Size, Share 2022
Anemia is a condition in which you don't have enough healthy red blood cells to carry adequate oxygen to the body's tissues.
This report contains market size and forecasts of Anemia Treatment Drugs in Global, including the following market information:
Global Anemia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anemia Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anemia Treatment Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anemia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Global Anemia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Global Anemia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anemia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anemia Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
| Report Attributes |
Report Details |
| Report Title |
Anemia Treatment Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anemia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anemia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anemia Treatment Drugs Overall Market Size
2.1 Global Anemia Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Anemia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anemia Treatment Drugs Players in Global Market
3.2 Top Global Anemia Treatment Drugs Companies Ranked by Revenue
3.3 Global Anemia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anemia Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anemia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anemia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anemia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anemia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anemia Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Supplements
4.1.3 Antibiotics
4.1.4 Immunosuppressant
4.1.5 Bone Marrow Stimulants
4.1.6 Corticosteroids
4.1.7 Gene Therapy
4.1.8 Iron Chelating Agents
4.2 By Type - Global Anemia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Anemia Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anemia Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anemia Treatment Drugs Market Size, 2021 & 2028
5.1.2 Iron deficiency anemia
5.1.3 Thalassemia
5.1.4 Aplastic anemia
5.1.5 Hemolytic anemia
5.1.6 Sickle cell anemia
5.1.7 Pernicious anemia
5.2 By Application - Global Anemia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Anemia Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anemia Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anemia Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anemia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Anemia Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anemia Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anemia Treatment Drugs Revenue, 2017-2028
6.3.2 US Anemia Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Anemia Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Anemia Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anemia Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Anemia Treatment Drugs Market Size, 2017-2028
6.4.3 France Anemia Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Anemia Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Anemia Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Anemia Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anemia Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Anemia Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anemia Treatment Drugs Revenue, 2017-2028
6.5.2 China Anemia Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Anemia Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Anemia Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anemia Treatment Drugs Market Size, 2017-2028
6.5.6 India Anemia Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anemia Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Anemia Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Anemia Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anemia Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Anemia Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Anemia Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anemia Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Anemia Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Anemia Treatment Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Corporate Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Anemia Treatment Drugs Major Product Offerings
7.2.4 Amgen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Amgen, Inc. Key News
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Corporate Summary
7.3.2 Hoffmann-La Roche Ltd. Business Overview
7.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Hoffmann-La Roche Ltd. Key News
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anemia Treatment Drugs Major Product Offerings
7.5.4 Novartis AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 Janssen Pharmaceutical
7.6.1 Janssen Pharmaceutical Corporate Summary
7.6.2 Janssen Pharmaceutical Business Overview
7.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Major Product Offerings
7.6.4 Janssen Pharmaceutical Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Janssen Pharmaceutical Key News
7.7 Bayer AG
7.7.1 Bayer AG Corporate Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Anemia Treatment Drugs Major Product Offerings
7.7.4 Bayer AG Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Bayer AG Key News
7.8 AMAG Pharmaceuticals
7.8.1 AMAG Pharmaceuticals Corporate Summary
7.8.2 AMAG Pharmaceuticals Business Overview
7.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Major Product Offerings
7.8.4 AMAG Pharmaceuticals Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 AMAG Pharmaceuticals Key News
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Corporate Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Major Product Offerings
7.9.4 GlaxoSmithKline plc Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline plc Key News
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Corporate Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Anemia Treatment Drugs Major Product Offerings
7.10.4 Akebia Therapeutics Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.10.5 Akebia Therapeutics Key News
7.11 Vifor Pharma Management, Ltd.
7.11.1 Vifor Pharma Management, Ltd. Corporate Summary
7.11.2 Vifor Pharma Management, Ltd. Business Overview
7.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Major Product Offerings
7.11.4 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.11.5 Vifor Pharma Management, Ltd. Key News
7.12 FibroGen, Inc.
7.12.1 FibroGen, Inc. Corporate Summary
7.12.2 FibroGen, Inc. Business Overview
7.12.3 FibroGen, Inc. Anemia Treatment Drugs Major Product Offerings
7.12.4 FibroGen, Inc. Anemia Treatment Drugs Revenue in Global Market (2017-2022)
7.12.5 FibroGen, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anemia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Anemia Treatment Drugs Market Drivers in Global Market
Table 3. Anemia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Anemia Treatment Drugs in Global Market
Table 5. Top Anemia Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anemia Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anemia Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anemia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Anemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Anemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anemia Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anemia Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer, Inc. Corporate Summary
Table 31. Pfizer, Inc. Anemia Treatment Drugs Product Offerings
Table 32. Pfizer, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Amgen, Inc. Corporate Summary
Table 34. Amgen, Inc. Anemia Treatment Drugs Product Offerings
Table 35. Amgen, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Product Offerings
Table 38. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Sharp & Dohme Corp. Corporate Summary
Table 40. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Product Offerings
Table 41. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Anemia Treatment Drugs Product Offerings
Table 44. Novartis AG Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Janssen Pharmaceutical Corporate Summary
Table 46. Janssen Pharmaceutical Anemia Treatment Drugs Product Offerings
Table 47. Janssen Pharmaceutical Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Anemia Treatment Drugs Product Offerings
Table 50. Bayer AG Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. AMAG Pharmaceuticals Corporate Summary
Table 52. AMAG Pharmaceuticals Anemia Treatment Drugs Product Offerings
Table 53. AMAG Pharmaceuticals Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline plc Corporate Summary
Table 55. GlaxoSmithKline plc Anemia Treatment Drugs Product Offerings
Table 56. GlaxoSmithKline plc Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Akebia Therapeutics Corporate Summary
Table 58. Akebia Therapeutics Anemia Treatment Drugs Product Offerings
Table 59. Akebia Therapeutics Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Vifor Pharma Management, Ltd. Corporate Summary
Table 61. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Product Offerings
Table 62. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 63. FibroGen, Inc. Corporate Summary
Table 64. FibroGen, Inc. Anemia Treatment Drugs Product Offerings
Table 65. FibroGen, Inc. Anemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anemia Treatment Drugs Segment by Type in 2021
Figure 2. Anemia Treatment Drugs Segment by Application in 2021
Figure 3. Global Anemia Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anemia Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anemia Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Janssen Pharmaceutical Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AMAG Pharmaceuticals Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline plc Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Akebia Therapeutics Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. FibroGen, Inc. Anemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
